Best Supplements to Help with Restless Legs Syndrome (RLS)

Restless legs syndrome affects 5-10% of adults and is one of the most under-recognized and misdiagnosed conditions in sleep medicine. The characteristic urge to move the legs—worse at rest, worse in the evening, temporarily relieved by movement—is often dismissed as stress or poor circulation when there is frequently a specific, identifiable, and correctable cause.

Iron deficiency is the most important. Correcting low ferritin can eliminate RLS symptoms entirely in a meaningful subset of patients. Before trying any supplement or medication for RLS, the right starting point is testing—particularly ferritin, vitamin D, folate, and B12.

The evidence-based options

1. Iron (Treat the Deficiency)

The relationship between iron deficiency and RLS is among the most well-established links between a nutrient deficiency and a neurological symptom. Research has documented low brain iron stores in RLS patients via post-mortem MRI studies and cerebrospinal fluid analysis, even when serum iron appears normal.

Mechanism: Iron is required for the function of tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis. The dopaminergic system—specifically the A11 spinal dopamine pathway—is central to RLS pathophysiology. Without adequate iron, dopamine signaling in the spinal cord is impaired, disrupting the inhibitory pathways that normally suppress the urge to move. This is why dopamine agonists (the primary pharmaceutical treatment for RLS) work—but it also explains why correcting iron deficiency addresses the same underlying mechanism naturally.

Critical detail—ferritin, not hemoglobin: Standard anemia testing (hemoglobin, hematocrit) is inadequate for RLS-related iron status. RLS symptoms can occur with serum ferritin well below 75-100 ng/mL, even with normal hemoglobin. The target ferritin for RLS management in most clinical guidelines is above 75 ng/mL; some researchers suggest 100-200 ng/mL for optimal neurological iron status. If your doctor checked only hemoglobin and told you your iron was "fine," request a serum ferritin specifically.

Evidence: A 2022 Cochrane review of iron therapy for RLS found significant improvement in symptom severity with oral and intravenous iron compared to placebo. A 2019 study in the Mayo Clinic Proceedings showed IV ferric carboxymaltose produced complete resolution of RLS symptoms in a substantial proportion of patients with low-normal ferritin.

Oral iron: Ferrous bisglycinate 25-30mg elemental iron every other day (alternate-day dosing improves absorption over daily dosing due to hepcidin regulation). Take on an empty stomach with vitamin C (500mg) to enhance absorption. Avoid taking with calcium, coffee, tea, or dairy—all significantly reduce iron absorption.

Intravenous iron: For patients who cannot absorb oral iron adequately or who have very low ferritin (<30 ng/mL) with severe RLS, IV iron (ferric carboxymaltose, ferumoxytol, or iron sucrose) produces much faster ferritin correction and often rapid symptom resolution. This requires physician administration.

Note: Do not supplement iron without testing. Iron overload (hemochromatosis) and elevated ferritin from inflammatory states require identification before supplementing.

2. Magnesium Glycinate

Magnesium is the most commonly used non-iron supplement for RLS, with substantial anecdotal support and plausible biological mechanisms, even if formal RCT evidence specifically for RLS is limited.

Mechanism: Magnesium acts as a natural calcium channel antagonist, reducing neuronal excitability and the repetitive firing that drives the uncomfortable leg sensations of RLS. It also relaxes smooth and skeletal muscle (reducing leg cramps and tension), supports GABA receptor function (reducing CNS excitability), and plays a role in dopamine receptor function.

Evidence: A 2012 open-label study (Sleep Medicine) found 12.4 mmol magnesium oxide improved sleep and periodic limb movements (PLM—often associated with RLS) in 10 patients over 4-6 weeks. Controlled trial evidence is limited, but the safety profile and plausible mechanism justify a therapeutic trial in most RLS patients.

Dosage: 400-600mg elemental magnesium as magnesium glycinate at bedtime. Glycinate is the preferred form—well-absorbed, low incidence of diarrhea (which occurs with oxide and citrate), and the glycine component provides additional mild sleep-promoting effects.

Timing: Take 1-2 hours before bed. Magnesium for RLS should be consistently timed with the pre-sleep period when symptoms are typically worst.

Note: Magnesium glycinate is well-tolerated by most people. Start at 200mg and increase to 400-600mg if tolerated. Loose stools indicate excess—reduce dose or switch to a lower dose with increased glycinate chelation.

3. Folate (Methylfolate B9)

Folate deficiency is associated with RLS, particularly in pregnancy—where RLS is dramatically more common (prevalence of 20-30% in pregnant women, versus 5-10% in the general population). Folate demands increase substantially during pregnancy, and deficiency is common.

Mechanism: Folate is required for the methylation cycle (the conversion of homocysteine to methionine), which supports dopamine synthesis and neurological function. Folate deficiency elevates homocysteine, which has neurotoxic effects and may impair the dopaminergic pathways involved in RLS. Folate is also required for DNA synthesis in rapidly dividing cells, including those of the developing nervous system.

Evidence: Observational studies have noted RLS improvement with folate supplementation in deficient patients. A study specifically in pregnancy-associated RLS found folate supplementation reduced symptoms. RLS in pregnancy is thought to be partly attributable to the dramatically increased folate requirements of pregnancy depleting available folate stores.

Dosage: 800-1000mcg methylfolate (5-methyltetrahydrofolate) daily. Methylfolate is the active, directly usable form—regular folic acid requires hepatic conversion that is impaired in individuals with MTHFR variants (present in approximately 40-60% of the population). Use methylfolate specifically, not folic acid, for neurological support.

Testing: Request serum folate and RBC folate (RBC folate is more reflective of tissue stores). Also check homocysteine—elevation suggests functional folate and/or B12 deficiency.

4. Vitamin D

Vitamin D deficiency is significantly overrepresented in RLS patients, and multiple case reports and small studies document dramatic symptom improvement after vitamin D correction in deficient individuals.

Mechanism: Vitamin D modulates dopaminergic function in the brain through vitamin D receptor activity in dopamine-producing neurons. It also regulates iron metabolism genes, so vitamin D deficiency can impair iron utilization even when ferritin is adequate. Additionally, vitamin D deficiency is associated with increased neurological excitability.

Evidence: A 2014 Turkish case-control study found significantly lower vitamin D levels in RLS patients than matched controls. A 2014 RCT (Sleep Medicine) showed vitamin D supplementation significantly reduced IRLS (International Restless Legs Scale) scores compared to placebo. Individual case reports of complete RLS resolution after vitamin D correction are published in the medical literature.

Dosage: Test first. Correct deficiency to 60-80 ng/mL (150-200 nmol/L) with 3,000-5,000 IU D3 plus 100-200mcg K2 daily. Retest after 3 months. The response to vitamin D correction is variable—some patients with low vitamin D and RLS respond dramatically, others see modest improvement.

5. Vitamin B12 (Methylcobalamin)

B12 is essential for neurological function and myelin integrity. B12 deficiency causes peripheral neuropathy, which can contribute to the abnormal leg sensations of RLS. B12 and folate work together in the methylation cycle, and deficiency of either impairs neurological function.

Mechanism: B12 is required for myelin synthesis. The peripheral neurological symptoms of B12 deficiency—paresthesias, burning, crawling sensations in the limbs—overlap significantly with RLS symptoms. In some cases, what presents as RLS may be partly or entirely B12-related neuropathy. B12 also participates in dopamine synthesis pathways through its role in methylation and SAM-e production.

Evidence: A 2014 Turkish study found significantly lower B12 levels in RLS patients. Case reports document RLS improvement or resolution with B12 supplementation in deficient patients. Evidence is mostly observational, but the safety profile and importance of ruling out deficiency make testing essential.

Dosage: 1000mcg methylcobalamin sublingually daily. Sublingual delivery bypasses gastric factor requirements, which is important because B12 absorption from food and standard oral supplements decreases significantly after age 50 due to reduced intrinsic factor and gastric acid.

Testing: Serum B12 alone can miss functional deficiency—request methylmalonic acid (MMA) and homocysteine. Elevated MMA with normal or borderline serum B12 indicates intracellular B12 deficiency. This is more common than appreciated, particularly in older adults.

6. Vitamin B6 (P5P Form)

B6 is involved in dopamine synthesis—it is a required cofactor for the enzyme L-DOPA decarboxylase (also called aromatic L-amino acid decarboxylase), which converts L-DOPA to dopamine. Since RLS pathophysiology centrally involves dopaminergic dysfunction, optimizing B6 status supports the dopamine synthesis that may be impaired.

Mechanism: In the dopamine synthesis pathway: tyrosine → L-DOPA → dopamine. The final step requires B6 as P5P. Iron deficiency impairs the first step (tyrosine hydroxylase); B6 deficiency impairs the second step. Both nutritional problems can contribute to reduced dopaminergic output in RLS-relevant pathways.

Evidence: B6 deficiency is associated with neurological and movement symptoms. Small studies and case series suggest B6 supplementation can improve leg restlessness symptoms, particularly in B6-deficient individuals. Direct RCT evidence for RLS specifically is limited.

Dosage: 25-50mg P5P (pyridoxal-5-phosphate) daily. Use only the active P5P form, not pyridoxine, for neurological applications—P5P does not require hepatic activation and is directly available to neurons. Do not exceed 200mg/day long-term—B6 toxicity (peripheral neuropathy) occurs above this threshold chronically.

7. Zinc

Zinc may help RLS through its role in the dopaminergic system. Zinc modulates dopamine transporter function and dopamine receptor sensitivity in the striatum, which is relevant to the central dopaminergic pathways affected in RLS.

Mechanism: Zinc is a cofactor for numerous neurological enzymes and appears to modulate dopamine neurotransmission in the basal ganglia and spinal cord. Low zinc may reduce dopamine receptor sensitivity in systems relevant to RLS.

Evidence: A 2013 Iranian case-control study found significantly lower serum zinc in RLS patients compared to controls. A small observational study suggested zinc supplementation improved IRLS scores. Evidence is preliminary and mechanistic, but zinc status is worth addressing given the safety profile and potential upside.

Dosage: 15-25mg elemental zinc as zinc picolinate or glycinate daily, if deficient. Take with food to reduce nausea. Balance with 1-2mg copper if supplementing long-term.

What doesn't work (or lacks evidence)

Calcium supplementation: Some older sources suggest calcium for leg cramps and RLS. Evidence for RLS specifically is not established. High calcium intake may actually impair iron absorption.

Melatonin as primary treatment: While melatonin can help with the sleep disruption caused by RLS, it does not address the underlying mechanism. Some evidence suggests melatonin may worsen periodic limb movements in some patients.

Valerian, hops, passionflower: These sedating herbs may help sleep but do not address RLS pathophysiology. They can mask symptoms without treating causes.

Kratom: Increasingly used informally for RLS—it activates opioid receptors, which explains anecdotal relief (opioids are a pharmaceutical treatment for severe RLS), but carries significant addiction and safety risks. Not recommended.

Test before you treat

This is the most important section in this article. RLS is one of the conditions where laboratory testing is most likely to reveal a specific correctable cause. Do not buy supplements without first checking:

Essential tests:

• Serum ferritin (not just hemoglobin—ferritin below 75-100 ng/mL is a target for treatment)
• Vitamin D (25-OH vitamin D)
• Serum and RBC folate
• Vitamin B12 (plus MMA and homocysteine for functional assessment)
• Serum zinc
• Thyroid panel (hypothyroidism can cause or worsen RLS)
• Kidney function (uremia is a cause of secondary RLS)

If ferritin comes back below 50-75 ng/mL, treat iron deficiency first and comprehensively. Some patients find this alone resolves their symptoms completely. Everything else is supplemental to this.

Medications: when supplements aren't enough

If laboratory testing is normal and targeted supplementation over 3 months does not produce adequate improvement:

Dopamine agonists (pramipexole, ropinirole): First-line pharmaceutical therapy. Highly effective but carry the risk of augmentation (worsening of symptoms with long-term use) and rare impulse control disorders.

Alpha-2-delta ligands (gabapentin, pregabalin): Increasingly preferred over dopamine agonists for long-term management due to lower augmentation risk. Particularly helpful when RLS is accompanied by pain or poor sleep.

Low-dose opioids: Used for severe refractory RLS; reserved for cases where other treatments fail.

Supplements and medications can be used together. Iron correction, for instance, is often pursued even in patients already on pharmaceutical RLS therapy, as improving iron status may allow dose reduction.

Building your stack

Start with testing. Then:

If ferritin is below 75 ng/mL:

1. Ferrous bisglycinate (alternate-day dosing) with vitamin C, away from meals and other supplements
2. Recheck ferritin at 8-12 weeks

If ferritin is adequate—add: 3. Magnesium glycinate 400-600mg at bedtime 4. Methylfolate 800mcg daily 5. Vitamin D3/K2 (to optimize levels)

If B12 or zinc are low—correct those concurrently.

If no single deficiency is primary: Add P5P 25-50mg alongside magnesium as a dopamine-pathway support approach.

Allow 8-12 weeks at each stage before concluding a supplement is ineffective. RLS is notoriously variable night to night, and meaningful trends require time to assess.

Lifestyle factors that matter

Caffeine and alcohol: Both can trigger or worsen RLS symptoms. Caffeine should be eliminated after noon. Alcohol may initially sedate but disrupts sleep architecture in the second half of the night, often triggering RLS during the early morning hours.

Exercise: Moderate aerobic exercise can reduce RLS severity, but vigorous or excessive exercise (particularly leg exercise) may transiently worsen symptoms in some patients—observe your individual pattern.

Stretching: Pre-sleep calf and hamstring stretching reduces symptom frequency in some patients. Simple and worth trying.

Heat and cold: Some patients find hot baths before bed helpful; others find cooling the legs (cool water, cooling pad) more effective. Experiment to find what modulates your symptoms.

Medications that worsen RLS: Many common medications exacerbate RLS, including SSRIs, SNRIs, tricyclic antidepressants, antihistamines (diphenhydramine), metoclopramide, and calcium channel blockers. Review any medications with your physician if RLS onset or worsening coincides with starting a new medication.

When to see a doctor

Seek medical evaluation if:

• RLS symptoms are significantly disrupting sleep or daily function
• Home testing reveals low ferritin, especially below 30-50 ng/mL (may need IV iron)
• Symptoms are severe, persistent, or spreading to arms or daytime
• You're pregnant with RLS symptoms (medication choices are limited; iron and folate supplementation are important)
• You suspect medication may be causing or worsening RLS
• Supplement trials over 3 months haven't produced adequate improvement

A sleep medicine physician or neurologist with experience in RLS is the appropriate specialist. A primary care physician with awareness of the ferritin threshold issue is also adequate for initial management.

The bottom line

Testing ferritin is the single most important step for anyone with RLS—low ferritin is the most common and most correctable cause, and correcting it can eliminate symptoms entirely without any other intervention. Vitamin D correction also produces dramatic responses in some patients. Magnesium glycinate at bedtime is the most practically useful supplement for most people, reducing neurological excitability and supporting sleep. Folate, B12, B6, and zinc support the dopamine synthesis pathway that underlies RLS pathophysiology. Test first, treat the identified deficiency comprehensively, and add supplements sequentially.

---

Track your RLS supplements and log symptom nights with Optimize. Start free.

Related Articles

• Supplements for Restless Leg Syndrome: Iron, Magnesium, and More